
The Federal Trade Commission issued an Opinion and Final Order in which the Commission upholds the Administrative Law Judge’s decision that the consummated acquisition of Freedom Innovations by Otto Bock HealthCare North America, Inc.—both top sellers of prosthetic knees equipped with microprocessors or MPKs—resulted in anticompetitive harm in the microprocessor prosthetic knee market, likely leading to higher prices and less innovation for amputee patients and prosthetic clinic customers. The acquisition was not reportable under the Hart-Scott-Rodino Act. The Commission’s order requires Otto Bock to divest the Freedom Innovations assets to an FTC-approved buyer.
Featured News
China Clears $8.2 Billion Bunge-Viterra Merger
Jun 16, 2025 by
CPI
UK Competition Watchdog Eyes Potential Evri-DHL Merger Over Market Concerns
Jun 16, 2025 by
CPI
Apple Faces New EU Ultimatum Over Digital Markets Act Violations
Jun 16, 2025 by
CPI
UK Competition Regulator Reviews Need for Google Ad Restrictions
Jun 15, 2025 by
CPI
Pork Producers Seek Immediate Appeal in Price-Fixing Case
Jun 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Industrial Policy
May 21, 2025 by
CPI
Industrial Strategy and the Role of Competition – Taking a Business Lens
May 21, 2025 by
Marcus Bokkerink
Industrial Policy, Antitrust, and Economic Growth: Some Observations
May 21, 2025 by
David S. Evans
Bolder by Design: Crafting Pro-Competitive Industrial Policies For Complex Challenges
May 21, 2025 by
Antonio Capobianco & Beatriz Marques
Competition-Friendly Industrial Policy
May 21, 2025 by
Philippe Aghion, Mathias Dewatripont & Patrick Legros